January 25, 2023 by Chain Drug Review
The NPD Group
Business, Leading Headlines, Retail News

CHICAGO — The focus on health and wellness evolved throughout the pandemic as consumers began seeking coping mechanisms for their altered lifestyles. The consumer’s need for normalcy at the height of the pandemic was the entry for a mental and physical health focus, reports The NPD Group. Compared to the pre-pandemic period, more consumers say
December 15, 2022 by Chain Drug Review
The NPD Group
Business, Leading Headlines, Retail News

PORT WASHINGTON, N.Y. — As the fastest-growing prestige beauty category in 2021, fragrance is showing signs of continued U.S. growth in 2022, including the all-important holiday season. Fragrance dollar sales grew by 4% from October 2 through December 3, 2022, compared to the same period in 2021, according to The NPD Group. The category also
November 9, 2022 by Chain Drug Review
holiday shopping, The NPD Group
Business, Leading Headlines, Retail News

PORT WASHINGTON, N.Y. — The number of consumers planning to shop online for the holidays fell from 85% last year to 80% this year, which is the largest ever shift favoring stores, according to the annual holiday purchase intentions survey from The NPD Group. This is also the first year, since before the pandemic, that
September 29, 2022 by Chain Drug Review
2022 holiday selling season, The NPD Group
Business, Leading Headlines, Retail News

PORT WASHINGTON, N.Y. — Increased negativity about the economy and their own personal finances is causing 29% of U.S. consumers to think about spending less this holiday season, according to a recent holiday purchase intentions consumer survey from The NPD Group,which recently merged with Information Resources, Inc. (IRI). While the majority of shoppers plan on spending the same or more
August 29, 2022 by Chain Drug Review
IRI, technology products, The NPD Group
Business, Leading Headlines, Retail News, Technology

PORT WASHINGTON, N.Y. — The NPD Group, which recently merged with Information Resources, Inc. (IRI), to create a leading global technology, analytics and data provider, today announced the latest findings from its Future of Technology forecast. NPD expects 2022 and 2023 will see 6% and 3% year over year revenue declines, respectively, but remain above
August 29, 2022 by Chain Drug Review
back-to-school shopping season, The NPD Group
Leading Headlines, Retail News

PORT WASHINGTON, N.Y. — Rising prices and consumers shopping for more immediate needs has disrupted early back-to-school shopping season performance. In the first seven weeks of the back-to-school shopping season, U.S. non-school-related general merchandise sales revenue grew 4%, while school spending fell short of last year’s results. In a recent survey, 41% of back-to-school shopping
June 21, 2022 by Chain Drug Review
beauty, The NPD Group
Business, Leading Headlines, Retail News

PORT WASHINGTON, N.Y.– Women in the U.S. are back to their former makeup habits — or even kicking them up a notch — now that most mask requirements have been lifted and more people are returning to workplaces, travel, and events. In fact, 70% of makeup wearers have returned to previous routines or are wearing
June 9, 2022 by Chain Drug Review
Sweets and Snacks Expo, The NPD Group
Supplier News

CHICAGO — The NPD Group announced the winners of its inaugural consumer awards during the Sweets and Snacks Expo, hosted by National Confectioners Association in Chicago, May 24-25. The awards, presented by NPD’s food and beverage practice to the winning sweets and snacks manufacturers, were based on the highest share of eatings together with needs,
April 7, 2022 by Chain Drug Review
IRI, The NPD Group
Leading Headlines, Retail News, Technology

CHICAGO — Information Resources, Inc. (IRI) and The NPD Group (NPD) announced on Thursday the signing of a definitive agreement through which IRI and NPD will merge. The combination will create a leading global technology, analytics and data provider that offers clients a view of total retail purchasing and consumption trends powered by advanced, predictive
March 14, 2022 by Chain Drug Review
The NPD Group
Business, Leading Headlines, Retail News

PORT WASHINGTON, N.Y. – It’s not all that shocking to note that over the course of the pandemic consumers focused more intensely on health and wellness. However, what is surprising is the fact that nearly two years after the pandemic hit the U.S. retail sales of products in health and wellness categories continue to match
January 24, 2022 by Chain Drug Review
The NPD Group
Business, Leading Headlines, Retail News

PORT WASHINGTON, N.Y. – The U.S. prestige beauty industry generated $22 billion in 2021, a 30% increase in dollar sales, versus 2020, according to The NPD Group. By category, fragrance outperformed all others in 2021 with sales up 49%, year-over-year, followed by hair products (up 47%), makeup (up 23%), and skincare (up 18%). In 2021, the
January 24, 2022 by Chain Drug Review
The NPD Group
Business, Leading Headlines, Retail News

PORT WASHINGTON, N.Y. – U.S. consumer spending on general merchandise ended the year up 15% compared to 2020, with a 6% increase in unit sales. While the holiday shopping brought positive retail results, the early part of the year delivered more significant year-over-year gains. The fourth quarter of 2021 contributed 9% revenue growth and 1%
December 6, 2021 by Chain Drug Review
The NPD Group
Business, Leading Headlines, Retail News

PORT WASHINGTON, N.Y. — Before the month of December began, U.S. sales revenue for discretionary general merchandise in 2021 had already reached 100% of the highest level reached in 2019 and 98% of the 2020 peak. According to The NPD Group, momentum through the early part of the year and holiday shopping season offset Black
September 20, 2021 by Chain Drug Review
The NPD Group
Business, Leading Headlines, Retail News

PORT WASHINGTON, N.Y. — As of July 2021, the majority of U.S. consumers planned to spend the same amount as last year on this year’s holiday shopping. Those who planned to spend less than last year outnumbered those who planned to spend more, according to a survey from The NPD Group. “The delta variant has